ATE383166T1 - Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration - Google Patents

Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration

Info

Publication number
ATE383166T1
ATE383166T1 AT99952872T AT99952872T ATE383166T1 AT E383166 T1 ATE383166 T1 AT E383166T1 AT 99952872 T AT99952872 T AT 99952872T AT 99952872 T AT99952872 T AT 99952872T AT E383166 T1 ATE383166 T1 AT E383166T1
Authority
AT
Austria
Prior art keywords
substances
cell regeneration
aim
oxytocin activity
oxytocin
Prior art date
Application number
AT99952872T
Other languages
English (en)
Inventor
Kerstin Uvnaes-Moberg
Thomas Lundeberg
Original Assignee
Entretech Medical Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Entretech Medical Ab filed Critical Entretech Medical Ab
Application granted granted Critical
Publication of ATE383166T1 publication Critical patent/ATE383166T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT99952872T 1998-09-25 1999-09-27 Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration ATE383166T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803272A SE9803272D0 (sv) 1998-09-25 1998-09-25 A drug for cell regeneration

Publications (1)

Publication Number Publication Date
ATE383166T1 true ATE383166T1 (de) 2008-01-15

Family

ID=20412731

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99952872T ATE383166T1 (de) 1998-09-25 1999-09-27 Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration

Country Status (8)

Country Link
EP (1) EP1115416B1 (de)
JP (1) JP2002525337A (de)
CN (1) CN1330550A (de)
AT (1) ATE383166T1 (de)
AU (1) AU6493199A (de)
DE (1) DE69937959D1 (de)
SE (1) SE9803272D0 (de)
WO (1) WO2000018424A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9915625D0 (en) * 1999-07-02 1999-09-01 Cortendo Ab Method
SE0001440D0 (sv) 2000-04-18 2000-04-18 Entretech Medical Ab A drug against climacteric disorders
SE0100684D0 (sv) 2001-02-28 2001-02-28 Kerstin Uvnaes Moberg New subject-matter
SE0102185D0 (sv) * 2001-06-19 2001-06-19 Uvnaes Moberg Kerstin New subject-matter
SE0102910D0 (sv) * 2001-08-31 2001-08-31 Moberg Kerstin Uvnaes New use
ES2315455T3 (es) * 2003-03-27 2009-04-01 Pantarhei Bioscience B.V. Uso de estrogenos para el tratamiento de infertilidad en maniferos machos.
SE536091C2 (sv) * 2011-04-14 2013-04-30 Pep Tonic Medical Ab Farmaceutisk komposition innehållande oxytocin eller fragment eller varianter därav och åtminstone en icke-jonisk cellulosaeter
DE102011118016A1 (de) * 2011-10-26 2013-05-02 Henkel Ag & Co. Kgaa Kosmetische Mittel enthaltend Oxytocin und Riechstoffe
RU2544462C1 (ru) * 2013-11-29 2015-03-20 Федеральное государственное бюджетное учреждение "Государственный научный центр Российской Федерации-Федеральный медицинский биофизический центр имени А.И. Бурназяна Федерального медико-биологического агентства" (ФГБУ "ГНЦ ФМБЦ им. А.И. Бурназяна ФМБА России") Способ профилактики развития острого панкреатита после операций на органах брюшной полости
US11414459B2 (en) 2017-09-28 2022-08-16 Kinoxis Therapeutics Pty Ltd Metabolite inspired selective oxytocin receptor agonists
JP7103886B2 (ja) * 2017-12-14 2022-07-20 花王株式会社 肌の質感改善剤の探索方法
JP2021172612A (ja) * 2020-04-24 2021-11-01 株式会社イーアール オキシトシンおよびプロトンポンプ阻害剤の組み合わせを含む薬剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4312913A1 (de) * 1992-10-23 1994-10-13 Knauf Siegfried Medikamentenzusammensetzung Oxytocin, Vasopressin und alphabetagamma-Endorphine
DE4236293A1 (en) * 1992-10-23 1993-03-04 Siegfried Knauf Use of oxytocin, vasopressin and endorphins - for treatment and prevention of e.g. immunological, neurological and organ diseases and conditions caused by pituitary disorder
SE9701162D0 (sv) * 1997-03-27 1997-03-27 Karolinska Innovations Ab New use II

Also Published As

Publication number Publication date
CN1330550A (zh) 2002-01-09
JP2002525337A (ja) 2002-08-13
AU6493199A (en) 2000-04-17
EP1115416B1 (de) 2008-01-09
EP1115416A1 (de) 2001-07-18
DE69937959D1 (de) 2008-02-21
SE9803272D0 (sv) 1998-09-25
WO2000018424A1 (en) 2000-04-06

Similar Documents

Publication Publication Date Title
TR199902383T2 (xx) Yeni pirimidin t�revleri ve bunlar�n haz�rlanmas� i�in proses.
MX9301751A (es) Acidos amido peroxicarboxilicos.
FR2715847B1 (fr) Composition contenant des acides nucléiques, préparation et utilisations.
DE69937959D1 (de) Verwendung von substanzen mit oxytocin aktivität mit dem ziel der zellregeneration
DE69331946D1 (de) Nukleozyme
ATE217754T1 (de) Verwendung von aerogelen in der landwirtschaft
DE69629670D1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
PT1091975E (pt) Nova ciclosporina com um perfil de actividade melhorado
BG103805A (en) Trifluoromethylalkylaminotriazolopyrimidines with fungicidal effect
DE69905906D1 (de) Kombination von zwei oder mehreren wirkstoffen unter verwendung von mikrokapsel-formulierungen
DE59806001D1 (de) MAGER-REGENERATION VON NOx-SPEICHERN
FI921279A7 (fi) Amino-b-lyaasientsyymin inhibiittorit deodorantteina
TR28071A (tr) Aktif agartma katalizörü olarak bir manganez kompleksini iceren bir agartma katalizör bilesimi.
DE69520056D1 (de) Verbindungen zur Hemmung von Thrombin
DE69934998D1 (de) Antisense modulation der expression von integrin alpha 4
BG103968A (en) Pharmaceutical antiviral composition containing glycirricinic acid and at least one protein with antiviral activity
BG103558A (en) Sulphonic acid or sulphonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
DE69914639D1 (de) Verschliessen von zellen mit aktiver rückwand
DE60132242D1 (de) Phosphonitliganden, katalysatorzusammensetzungen und dessen verwendung in hydroformylierungsprozess
EE9900477A (et) Ühendid ja kompositsioonid seriinproteaasse, eriti trüptaasse aktiivsusega seotud haiguste raviks
FI972684A7 (fi) Piperidiinietikkahappojohdannaisia, joita voidaan käyttää fibrinogeeni antagonisteina
MX210235B (es) Oxiranil-triazolintionas y su empleo como microbicidas
ATE207533T1 (de) Endo-beta-1,4-glukanase und ihre entsprechende dna
DE59813664D1 (de) Verfahren zum screening von antimykotisch wirkenden substanzen
UA15920A (uk) Аміди циклометілеh-1, 2-дикарбоhових кислот, які мають гіпотеhзивhу активhість

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties